Skip to main content
Year archive

Jagsonpal Pharmaceuticals Limited — 2020 filings

All 79 regulatory filings released by Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) in 2020, sourced directly from the official regulator.

79 Filings
2020 Period
2020 filings (79)
Filing Released Lang
Related Party Transactions
Regulatory Filings
2020-12-07 English
Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find enclosed disclosure of Related Party Transaction, ....
Regulatory Filings
2020-12-07 English
Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find enclosed herewith disclosure of Related Party Transaction, ....
Regulatory Filings
2020-12-07 English
Reply To Clarification Sought By National Stock Exchange Of India Ltd. On Price Movement.
Regulatory Filings
2020-11-19 English
Price movement
Regulatory Filings
2020-11-19 English
SUBMISSION OF UN-AUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2020.
Regulatory Filings
2020-11-10 English
Financial Result Updates
Regulatory Filings
2020-11-10 English
Outcome of Board Meeting
Regulatory Filings
2020-11-10 English
We wish to inform you that the Board of Directors of the Company at their meeting held today, (i.e. Tuesday, the 10th Day of November, 2020), have inter alia, approved and taken on record ....
Regulatory Filings
2020-11-10 English
Board Meeting — Financial Results
Regulatory Filings
2020-11-02 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve the Un-Audited Financial ....
Regulatory Filings
2020-11-02 English
SUBMISSION OF CERTIFICATE UNDER SUB - REGULATION 9 & 10 REGULATION 40 OF THE SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENT) REGULATIONS, 2015 FOR THE HALF YEAR ENDED ON 30th SEPTEMBER, 2020.
Regulatory Filings
2020-10-28 English
Compliance Certificate (Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the Half Year ended 30th September, 2020.
Regulatory Filings
2020-10-20 English
Updates
Regulatory Filings
2020-10-20 English
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30 September, 2020.
Regulatory Filings
2020-10-20 English
Shareholders meeting
Regulatory Filings
2020-09-30 English
Voting results of 41st Annual General Meeting in terms of Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
Regulatory Filings
2020-09-30 English
Trading Window
Regulatory Filings
2020-09-30 English
Shareholders meeting
Regulatory Filings
2020-09-30 English
Intimation of Closure of Trading Window.
Regulatory Filings
2020-09-30 English
Proceeding of the 41st Annual General Meeting held on 30th September, 2020.
Regulatory Filings
2020-09-30 English
Copy of Newspaper Publication
Regulatory Filings
2020-09-08 English
In continuation of our letter dated September 05, 2020 we are enclosing copies of the newspaper advertisements published in this regard on September 08, 2020, in 'Business Standard' (English) ....
Regulatory Filings
2020-09-08 English
Shareholders meeting
Regulatory Filings
2020-09-05 English
Record Date
Regulatory Filings
2020-09-05 English
Book Closure
Regulatory Filings
2020-09-05 English
The Book Closure i.e. Register of Members and the Share Transfer Books of the Company will remain closed from 24th September, 2020 to 30th September, 2020 (both days inclusive) for the ....
Regulatory Filings
2020-09-05 English
Submission of Annual Report as per the provisions of Reg. 34 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2020-09-05 English
Intimation for Notice of 41st Annual General Meeting to be held through Video Conferencing or Other Audio Visual Means, Book Closure and Record Date for remote E- voting and Dividend Eligibility.
Regulatory Filings
2020-09-05 English
Updates
Regulatory Filings
2020-09-03 English
We wish to inform you that 41st Annual General Meeting of the Company to be held on Wednesday, September 30, 2020, at 11:00 A.M. through Video Conferencing/ Other Audio Visual Means. ....
Regulatory Filings
2020-09-03 English
Related Party Transactions
Regulatory Filings
2020-08-24 English
Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find enclosed disclosure of Related Party Transaction, ....
Regulatory Filings
2020-08-24 English
Updates
Regulatory Filings
2020-08-07 English
Pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following documents as required ....
Regulatory Filings
2020-08-07 English
Reply to Clarification- Financial results
Regulatory Filings
2020-08-07 English
Reply to Clarification- Financial results
Regulatory Filings
2020-08-06 English
Financial Results Updates
Regulatory Filings
2020-07-29 English
Audited financial results for the quarter and year ended 31 March, 2020 along with Audit Report.
Regulatory Filings
2020-07-29 English
Financial Result Updates
Regulatory Filings
2020-07-29 English
Unaudited Financial Results for the quarter ended 30 June, 2020 along with Limited Review Report
Regulatory Filings
2020-07-29 English
Financial Result Updates
Regulatory Filings
2020-07-29 English
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 29, 2020, inter alia, has recommended Dividend @ 10% on Equity shares ....
Regulatory Filings
2020-07-29 English
Outcome of Board Meeting
Regulatory Filings
2020-07-29 English
The board of director at their meeting held today has declared a dividend of 10 % per equity shares subject to the approval of the shareholders at the ensuing Annual General Meeting for ....
Regulatory Filings
2020-07-29 English
Dividend
Regulatory Filings
2020-07-29 English
Audited financial results for the quarter and year ended 31 March, 2020 along with Audit Report.
Regulatory Filings
2020-07-29 English
We wish to inform you that the Board of Directors of the Company at their meeting held today, (i.e. Wednesday, the 29th Day of July, 2020), have inter alia, approved and taken on record ....
Regulatory Filings
2020-07-29 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2020-07-24 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve Audited Financial ....
Regulatory Filings
2020-07-24 English
Updates
Regulatory Filings
2020-07-13 English
In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate received from M/s MCS Share Transfer ....
Regulatory Filings
2020-07-13 English
Pursuant to Regulation 24 A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1//27/2019 dated February 8, 2019, please ....
Regulatory Filings
2020-07-01 English
Updates
Regulatory Filings
2020-07-01 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and advisory issued by the Securities and Exchange ....
Regulatory Filings
2020-07-01 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2020-06-26 English
Reply To Clarification Sought By The Exchange.
Regulatory Filings
2020-06-25 English
With reference to the clarification sought by you, please note that the Company is in compliant with all the necessary disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations ....
Regulatory Filings
2020-06-24 English
Price movement
Regulatory Filings
2020-06-24 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-06-08 English
Certificates under Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2020-05-27 English
Updates
Regulatory Filings
2020-05-13 English
In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate received from M/s MCS Share Transfer ....
Regulatory Filings
2020-05-13 English
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Compliance Certificate, ....
Regulatory Filings
2020-05-13 English
With reference to the clarification sought by National Stock Exchange of India Ltd, please note that the Company is in compliant with all the necessary disclosures pursuant to Regulation ....
Regulatory Filings
2020-04-10 English
With reference to the clarification sought by National Stock Exchange of India Ltd, please note that the Company is in compliant with all the necessary disclosures pursuant to Regulation ....
Regulatory Filings
2020-04-10 English
Price movement
Regulatory Filings
2020-04-10 English
Trading Window
Regulatory Filings
2020-03-31 English
The Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited ("the Company") shall remain closed for Designated Persons and their immediate relative(s) with effect ....
Regulatory Filings
2020-03-31 English
Financial Result Updates
Regulatory Filings
2020-02-13 English
Unaudited financial results
Regulatory Filings
2020-02-13 English
Outcome of Board Meeting. The meeting was commenced at 12:00 Noon and concluded at 16:05.
Regulatory Filings
2020-02-13 English
Outcome of Board Meeting
Regulatory Filings
2020-02-13 English
Board Meeting — Financial Results
Regulatory Filings
2020-02-03 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve the Unaudited Financial ....
Regulatory Filings
2020-02-03 English
Updates
Regulatory Filings
2020-01-13 English
In Compliance with Regulation 74 (5) of SEBl (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate received from M/s MCS Share Transfer ....
Regulatory Filings
2020-01-13 English
Trading Window
Regulatory Filings
2020-01-02 English
The Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited ("the Company") shall remain closed for Designated Persons and their immediate relative(s) with immediate ....
Regulatory Filings
2020-01-02 English